Life Sciences

For startups with breakthroughs in biology, medicine, and healthcare.

 

Life Sciences

For startups with breakthroughs in biology, medicine, and healthcare.

Startups in the Life Sciences track are developing translational treatments and tools that address unmet health needs.

The Life Sciences track is for startups tackling complex problems in biology, chemistry or related fields with applications in therapeutics, drug discovery, drug design, delivery, diagnostics, and other human or animal health-focused verticals.

Startups in the Life Sciences track are developing translational treatments and tools that address unmet health needs.

The Life Sciences track is for startups tackling complex problems in biology, chemistry or related fields with applications in therapeutics, drug discovery, drug design, delivery, diagnostics, and other human or animal health-focused verticals.

 

Industry Guidance

Industry executives can help you develop your roadmap to land strategic partnerships, gain regulatory approval, or acquire customers

Operational and Scientific Mentorship

Seasoned operators that have taken their companies through successful exits will support your high-level business development strategy, while leading scientists can help shape your R&D strategy

Life Sciences Investors

Vertical-specific investors will give you critical advice from a “smart money” perspective. They will help you craft your pitch, outline the milestones needed to raise capital, and may invest

Life Sciences Startups

Immunai is mapping the immune system with single-cell biology and AI to power new therapeutic discoveries.

EVQLV develops AI engineered with life science data to provide a library of therapeutic candidates with low likelihood of downstream failure.

C2i Genomics provides diagnostics-as-a-service (DaaS) using a cloud-based platform to analyze DNA sequences for cancer markers.

PhAST Diagnostics is developing an AI-based computer vision technology to help tackle the global healthcare threat of antibiotic resistance.

 

Mytide Therapeutics created a biofabrication platform for synthetic peptide and protein drug discovery, as well as development of clinical treatments to overcome molecular scarcity.

A2A Pharmaceuticals develops therapeutics against specific biological targets, leveraging AI and fragment-based discovery to optimize drug design.

 

VIEW ALL

Industry Guidance

Industry executives can help you develop your roadmap to land strategic partnerships, gain regulatory approval, or acquire customers

Operational and Scientific Mentorship

Seasoned operators that have taken their companies through successful exits will support your high-level business development strategy, while leading scientists can help shape your R&D strategy

Life Sciences Investors:

Vertical-specific investors will give you critical advice from a “smart money” perspective. They will help you craft your pitch, outline the milestones needed to raise capital, and may invest

Life Sciences Companies

Comprehensively mapping the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development, and improve patient outcomes.

EVQLV develops AI engineered with life science data to provide a library of therapeutic candidates with low likelihood of downstream failure.

C2i Genomics provides diagnostics-as-a-service (DaaS) using a cloud-based platform to analyze DNA sequences for cancer markers.

PhAST Diagnostics is developing an AI-based computer vision technology to help tackle the global healthcare threat of antibiotic resistance.

Cytonus Therapeutics has developed the Cargocyte platform, which delivers therapeutic payloads to cells in oncology, inflammation, and other diseases

A2A Pharmaceuticals develops therapeutics against specific biological targets, leveraging AI and fragment-based discovery to optimize drug design.

VIEW ALL

Hear From Our Startups

“The biggest outcome from the program was taking what we had, which was a scientific development plan, and turning that into a business development plan…our mentors helped us to actually strategize, gain interest and eventually close on financing for the company”

Jacob Becraft
Founder and CEO, Strand Therapeutics

EFL Mentors

Our mentors are renowned physician-scientists, and successful operators who have created highly influential life science companies. They can support you on clinical study design, IP strategy, target validation, business model, market access, and pipeline valuation.

Sharon Mates

Founder, Chairman and CEO, Intra-Cellular Therapies

Arthur Klausner

President and CEO, Goldilocks Therapeutics, Inc.

Rana Al-Hallaq

Senior Director and Partner, Pfizer Ventures

Adam Sharkawy

Co-Founder and Managing Partner, Material Impact

Bob Schneider

Associate Dean and Professor, Radiation and Oncology, NYU Langone Health

Rebecca Luse

Principal at Deep Track Capital

Avi Rosenbaum

Partner, Tectonic Capital

All Mentors

EFL Mentors

Our mentors are renowned physician-scientists, and successful operators who have created highly influential life science companies. They can support you on clinical study design, IP strategy, target validation, business model, market access, and pipeline valuation.

Sharon Mates

Founder, Chairman and CEO, Intra-Cellular Therapies

Arthur Klausner

President and CEO, Goldilocks Therapeutics, Inc.

Rana Al-Hallaq

Senior Director and Partner, Pfizer Ventures

Adam Sharkawy

Co-Founder and Managing Partner, Material Impact

Bob Schneider

Associate Dean and Professor, Radiation and Oncology, NYU Langone Health

Avi Rosenbaum

Partner, Tectonic Capital

All Mentors